Paul Clarke

Prof. Paul Clarke

UQ Diamantina Institute, The University of Queensland, Brisbane, Australia
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2003 in Nature Cell Biology
Verified
Journal Article
Closed access
LALindsey A. Allan
Lindsey A. Allan
NMNick Morrice
Nick Morrice
SBSuzanne Brady
Suzanne Brady
GMGareth Magee
Gareth Magee
SPShalini Pathak
Shalini Pathak
Paul ClarkePaul Clarke
Paul Clarke

14 May 2008 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
Paul ClarkePaul Clarke
Paul Clarke
CZChuanmao Zhang
Chuanmao Zhang

1 December 1989 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
DCDavid Carling
David Carling
Paul ClarkePaul Clarke
Paul Clarke
VZVictor A. Zammit
Victor A. Zammit
DHDavid Grahame Hardie
David Grahame Hardie
1 We have purified the AMP-activated protein kinase 4800-fold from rat liver. The acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA(HMG-CoA) reductase kinase activities copurify through all six purification steps and are inactivated with similar kinetics by treatment with the reactive ATP analogue fluorosulphonylbenzoyladenosine. 2 The final preparation contains several polypeptides detectable by SDS/polyacrylamide gel electrophoresis, but only one of these, with an apparent molecular mass of 63 kDa, is labelled using [14C]fluorosulphonyl-benzoyladenosine. This is also the only polypeptide in the preparation that becomes significantly labelled during incubation with [γ32P]ATP. This autophosphorylation reaction did not affect the AMP-stimulated kinase activity. 3 In the absence of AMP the purified kinase has apparent Km values for ATP and acetyl-CoA carboxylase of 86 μM and 1.9 μM respectively. AMP increases the Vmax 3–5-fold without a significant change in the Km for either protein or ATP substrates. 4 The response to AMP depends on the ATP concentration in the assay, but at a near-physiological ATP concentration the half-maximal effect of AMP occurs at 14 μM. Studies with a range of nucleoside monophosphates and diphosphates, and AMP analogues showed that the allosteric activation by AMP was very specific. ADP gave a small stimulation at low concentrations but was inhibitory at high concentrations. 5 These results show that the AMP-activated protein kinase is the major HMG-CoA reductase kinase detectable in rat liver under our assay conditions and that it is therefore likely to be identical to previously described HMG-CoA reductase kinase(s) which are activated by adenine nucleotides and phosphorylation. The AMP-binding and catalytic domains of the kinase are located on a 63-kDa polypeptide which is subject to autophosphorylation.

4 June 2010 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MHMargaret E Harley
Margaret E Harley
LALindsey A Allan
Lindsey A Allan
HSHelen S Sanderson
Helen S Sanderson
Paul ClarkePaul Clarke
Paul Clarke
The balance between cell cycle progression and apoptosis is important for both surveillance against genomic defects and responses to drugs that arrest the cell cycle. In this report, we show that the level of the human anti‐apoptotic protein Mcl‐1 is regulated during the cell cycle and peaks at mitosis. Mcl‐1 is phosphorylated at two sites in mitosis, Ser64 and Thr92. Phosphorylation of Thr92 by cyclin‐dependent kinase 1 (CDK1)–cyclin B1 initiates degradation of Mcl‐1 in cells arrested in mitosis by microtubule poisons. Mcl‐1 destruction during mitotic arrest requires proteasome activity and is dependent on Cdc20/Fizzy, which mediates recognition of mitotic substrates by the anaphase‐promoting complex/cyclosome (APC/C) E3 ubiquitin ligase. Stabilisation of Mcl‐1 during mitotic arrest by mutation of either Thr92 or a D‐box destruction motif inhibits the induction of apoptosis by microtubule poisons. Thus, phosphorylation of Mcl‐1 by CDK1–cyclin B1 and its APC/CCdc20‐mediated destruction initiates apoptosis if a cell fails to resolve mitosis. Regulation of apoptosis, therefore, is linked intrinsically to progression through mitosis and is governed by a temporal mechanism that distinguishes between normal mitosis and prolonged mitotic arrest. There is a [Have you seen ...?][1] (July 2010) associated with this Article. [1]: http://dx.doi.org/10.1038/emboj.2010.150

1 April 2007 in Molecular Cell
Verified
Journal Article
Closed access
LALindsey A. Allan
Lindsey A. Allan
Paul ClarkePaul Clarke
Paul Clarke

8 October 2009 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
LALindsey A. Allan
Lindsey A. Allan
Paul ClarkePaul Clarke
Paul Clarke